logo
Plus   Neg
Share
Email

Stock Alert: LAIX Jumps To New 52-week High

Shares of LAIX Inc. (LAIX), a China-based AI company that provides online English learning products and services, are skyrocketing more than 314 percent or $8.05 in Friday's morning trade at $10.61, after hitting a new 52-week high of $11.65 despite no company-centric news.

U.S. stocks are rising on Friday after a report by the Labor Department report showed a modest rebound in employment in the month of January. The markets are also benefiting from more upbeat news on the corporate earnings front as well as news that Johnson & Johnson has applied for an emergency use authorization from the FDA for its single-dose coronavirus vaccine.

LAIX has traded in a range of $1.36 to $11.65 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Editors Pick
Johnson & Johnson's (JNJ) Covid-19 vaccine is expected to be back on track as early as this weekend as a decision is expected after the advisory panel meeting of the U.S. Centers for Disease Control and Prevention (CDC) slated on April 23, according to Dr. Anthony Fauci, the chief medical adviser to President Joe Biden. MK-4482, the experimental antiviral drug for COVID-19, showed promise to prevent and treat SARS-CoV-2 infection in hamster study, according to the scientists of National Institutes of Health or NIH. The drug significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection. MK-4482, delivered orally, is now in Phase 2 and 3 human clinical studies. Beverages giant Coca-Cola reported a 19 percent decline in profit for the second quarter from last year as a revenue growth of 5 percent and improved margins were offset by higher income taxes and interest expense. However, adjusted earnings per share and revenues topped analysts' expectations. The company also maintained its adjusted earnings and organic revenue growth outlook for fiscal 2021.
Follow RTT